European Companies Search Engine

EU funding (€7,742,500): Propelling the shift toward the future of circular, safe and sustainable packaging and single use device ecoDesigned solutions through healthcare environments Hor24 Dec 2024 EU Research and Innovation programme "Horizon"

Text

Propelling the shift toward the future of circular, safe and sustainable packaging and single use device ecoDesigned solutions through healthcare environments

The healthcare sector is hindered by several barriers that hamper the application of circular economy principles (e.g. the safety restrictions of the domain limit the use of recycled materials due to the need of materials biocompatibility, and safety in products to be used in the human body). Led by a multidisciplinary consortium of 39 partners (plus 13 industry affiliates) from 15 EU countries plus UK and USA, ENKORE aim to tackle challenges and develop an ecoDesign framework that supports the development of safe and environmental compliant devices eco-responsible packaging, which minimize the environmental impact, reduce the carbon footprint, and maximize the use and preservation of resources. The main goal is to connect the design of the medical devices packages with the end-of-life stage, thus the technologies that support circularity are taken into account at the medical device conception stage. ENKORE framework will be validated in 5 Reference Use Cases (RUCs), led by 5 different health regions that bring HPCs and policy maker, 3 large EU hospitals and the reference network for European Regional and Local Health Authorities (EUREGHA). The project developments and RUCs are supported by several associations and NGOs, a packaging manufacturer and a group of SMEs and researchers, specialists in circularity, LCA, social sciences, environment, circularity, and materials. The validation of the framework shall provide evidence to work with policymakers, creating new or revised standards and create tangible/quantitative evidence. Policy making and regulatory engagement will be strongly performed. The methods and tools comprise Environmental and Social Life Cycle Assessment (ELCA/SLCA), Circularity Calculator (CC) and Digital Product Passport (DPP) approaches, which could be adapted during the second stage of the proposal.


Funded Companies:

Company name Funding amount
Boehringer Ingelheim Pharmaceuticals Inc. ?
Active Ageing Association €185,000
Agenzia Regionale Per LA Salute Ed IL Sociale €250,000
Baxter R AND D Europe €0.00
BOEHRINGER INGELHEIM INTERNATIONALGESELLSCHAFT mbH €0.00
CHARITE - UNIVERSITAETSMEDIZIN BERLIN €349,000
Consorcio Mar Parc de Salut de Barcelona €250,000
Dupont DE Nemours (Luxembourg) Sàrl €0.00
ELI LILLY AND COMPANY €0.00
Enosi Asthenon Elladas €205,000
European Regional AND Local Health Authorities ASBL €253,750
Fondazione Policlinico Universitario Campus BIO Medico €335,700
Forum des Patients Europeens €88,750
FRESENIUS MEDICAL CARE DEUTSCHLAND GmbH €0.00
Fundacion Universidad Francisco de Vitoria €229,250
Happy Mondays Communication SL €432,500
Idryma Technologias Kai Erevnas €206,875
Institoyto Bioiatrikis Texnologias €221,500
INTERNATIONAL SOLID WASTE Association €150,000
JOHNSON & JOHNSON MEDICAL GmbH €0.00
Medtronic Iberica SA €0.00
Multimed Engineers Srl €203,125
Naucnoistrazivacki Institut Verlab ZA Biomedicinski Inzinjering Medicinske Uredaje I Vjestacku Inteligenciju €192,813
Novo Nordisk A/S €0.00
Osai Automation System S.p.A. Societa' Benefit €293,750
PFIZER Inc. €0.00
Politechnika Poznanska €290,238
Predictby Research And Consulting SL €498,750
SAMENWERKENDE TOPKLINISCHE OPLEIDINGSZIEKENHUIZEN €393,750
Servicio Madrileno de Salud €211,875
Sofradim Production Sasu €0.00
Sterimed Holding €481,250
TAKEDA PHARMACEUTICALS INTERNATIONAL AG €0.00
Tech Hive Labs Astiki Mi Kerdoskopiki Etaireia €347,500
Universidad Politecnica de Madrid €578,125
Universita Campus BIO Medico Di Roma €391,250
UNIVERSITEIT LEIDEN €469,000
Uniwersytet Medyczny w Lodzi €233,750

Source: https://cordis.europa.eu/project/id/101166707

The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, United States.

Creative Commons License The visualizations for "Boehringer Ingelheim Pharmaceuticals Inc. - EU funding (€7,742,500): Propelling the shift toward the future of circular, safe and sustainable packaging and single use device ecoDesigned solutions through healthcare environments" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.